Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03479476 · ClinicalTrials.gov registry record · Phase 2
A Trial of Metformin in Individuals With Fragile X Syndrome
A Phase 2 study, sponsored by University of California, Davis.
- Completed
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
NCT03479476 is a Phase 2 study that has completed, run by University of California, Davis. The registered enrollment target is 120 participants.
The verdict
NCT03479476, a Phase 2 study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
Study Summary
This study is a controlled trial of metformin in individuals with fragile X syndrome between the ages of 6 and 25 years. Participants will be randomized in a double-blind design to either drug or placebo and will attend three visits to the study site in a 4-month period for a series of tests. The primary objectives are to assess safety, tolerability, and efficacy of metformin in the treatment of language deficits, behavior problems, and obesity/excessive appetite in individuals with fragile X syndrome.
Interventions
- DRUG Metformin
- DRUG Placebo Medication
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2018-04-30 |
| Est. Completion | 2024-05-22 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03479476
The ClinicalTrials.gov registry entry for NCT03479476 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Metformin is the first listed.
NCT03479476 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03479476 about?
NCT03479476 is a clinical study titled "A Trial of Metformin in Individuals With Fragile X Syndrome". This study is a controlled trial of metformin in individuals with fragile X syndrome between the ages of 6 and 25 years. Participants will be randomized in a double-blind design to either drug or placebo and will attend three visits to the study site in a 4-month period for a series of tests. The pr...
What is the current status of trial NCT03479476?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2018-04-30. Estimated completion is 2024-05-22.
What interventions are being tested in trial NCT03479476?
The interventions under investigation include: Metformin (DRUG), Placebo Medication (DRUG).
Who is sponsoring clinical trial NCT03479476?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.